Raymond James & Associates Ark Genomic Revolution ETF (De Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Raymond James & Associates holds 60,535 shares of ARKG stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,535
Previous 82,411
26.55%
Holding current value
$1.49 Million
Previous $1.94 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ARKG
# of Institutions
285Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$89.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$85.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$68.7 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$68.5 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$40.8 Million0.02% of portfolio